Compare LI & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LI | CNC |
|---|---|---|
| Founded | 2015 | 1984 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.8B | 21.5B |
| IPO Year | N/A | 2001 |
| Metric | LI | CNC |
|---|---|---|
| Price | $18.39 | $38.37 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 10 | 17 |
| Target Price | $19.66 | ★ $41.94 |
| AVG Volume (30 Days) | 2.9M | ★ 4.6M |
| Earning Date | 05-28-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $194,777,000,000.00 |
| Revenue This Year | $18.98 | $8.30 |
| Revenue Next Year | $22.72 | $1.06 |
| P/E Ratio | $29.50 | ★ N/A |
| Revenue Growth | N/A | ★ 19.44 |
| 52 Week Low | $15.71 | $25.08 |
| 52 Week High | $32.03 | $63.42 |
| Indicator | LI | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 52.64 | 58.56 |
| Support Level | $16.30 | $37.25 |
| Resistance Level | $18.94 | $39.61 |
| Average True Range (ATR) | 0.40 | 1.17 |
| MACD | 0.02 | 0.69 |
| Stochastic Oscillator | 45.18 | 96.54 |
Li Auto is a leading Chinese NEV manufacturer that designs, develops, manufactures, and sells premium smart NEVs. The company started volume production of its first model Li One in November 2019. The model is a six-seater, large, premium plug-in electric SUV equipped with a range extension system and advanced smart vehicle solutions. It sold over 500,000 NEVs in 2024, accounting for about 4% of China's passenger new energy vehicle market. Beyond Li One, the company expands its product line, including both BEVs and PHEVs, to target a broader consumer base.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.